Posted 9 September 2024
Homemark continues to dupe customers claiming, now for years, that this treatment can fix broken nails, fungal infections, etc, in spite of numerous ASA/ARB (Advertising Regulatory Board) rulings against the claims. The rulings are valid for Homemark is unable to supply a shred of evidence to back up its claims.
Now two consumers coincidentally laid a new complaint with the ARB arguing that this product is no more than a ‘scam’. The ARB asked Homemark for evidence for their claims, which Homemark was unable to supply and hence a ruling against Homemark followed.
Decision of the ADVERTISING REGULATORY BOARD
Advertiser – Homemark (Pty) Ltd
Consumer/Competitor – Consumer
File reference -3392 – Homemark Aragan Secret Nail Treatment Oil
Outcome – Partial uphold
Date – 6 September 2024
The Directorate of the Advertising Regulatory Board has been called upon to consider two consumer complaints against a commercial broadcast on DStv at the end of July 2024.
Description of the advertising
The Commercial “introduces” the Advertiser’s “… tried and tested Aragan Secret Nail Treatment Oil, which is harvested from the Aragan tree found only in Marrocco …” It explains that this oil contains various oils which ensure “… low pH levels to not only keep your nails smooth and attractive …” and features various visuals of people applying this to their fingernails or toenails (some of which appear chipped or discoloured), with words such as “Strong” and “Moisturised” appearing on-screen. In one scene, an animated image shows, what appears to be badly damaged or infected nail being treated with this oil, and transforming into a clear, smooth nail.
Complaints
The First Complainant made reference to claims that this product “fights fungus and eczema”, and referred to previous ARB rulings and sanctions against such claims for this product. He stated that:
“… on 24 November 2020, the ARB Directorate found that the claims communicated in this commercial are unsubstantiated and in breach of Clause 4.1 of Section II of the Code.
The ARB stared that members of the ARB and broadcasters should be advised not to accept advertising from the Advertiser for its Aragan Secret Nail Treatment. The ARB Directorate should again sanction this broadcaster for accepting this advertising.”
The Second Complainant referred to “numerous” rulings against this product dating back as far as 2013. He acknowledged that the advertising has been changed slightly, but objected strongly to the Advertiser’s continued deception of consumers, which is not only disadvantageous to consumers, but also brings advertising into disrepute. This Complainant highlighted “the clear claim to treat nails with fungal disease, and other disease conditions” as problematic. He further objected to the fact that the commercial now claims that the product has been “tried and tested”.
Response
The Advertiser submitted that its commercial makes no reference to an ability to treat fungus or eczema. It speculated that, perhaps, the broadcaster flighted the incorrect commercial, which it will address with the broadcaster.
Dealing with this commercial, it submitted that no medicinal claims are made, and argued that the product is “tried and tested” as it is imported from the European Union, where products must meet rigorous consumer standards before being placed on the market. The Advertiser further submitted that claiming to be “tried and tested” does not constitute a medicinal claim or a claim that requires substantiation.
Application of the Code of Advertising Practice
The ARB considered the following provisions of the Code to be relevant to this dispute:
- Clause 4.1 of Section II (Substantiation);
- Clause 4.2.1 of Section II (Misleading claims);
- Clause 15 of the Procedural Guide (Enforcement of rulings).
Decision
Having considered all the material before it, the Directorate of the ARB issues the following finding.
The Directorate must determine whether:
- The Advertiser is still making the same or materially similar unsubstantiated claims as those ruled against before, and
- Whether the Advertiser holds appropriate evidence for any of its current claims (failing which, the claims would arguably be unsubstantiated and likely to mislead).
Both complainants alleged that the Advertiser appears to be disregarding earlier ARB decisions. Both complainants submitted that references to eczema and fungus still appear. The second complainant submitted that it was unbelievable that the Advertiser continues to promote unsubstantiated claims for this product, and objected to the claim that this was a “tried and tested” product.
In Homemark Aragon Oil – Dr Harris Steinman (13 March 2019), the Directorate ruled that the Advertiser did not provide adequate substantiation to show that its Aragan Nail Oil is capable of fighting “fungus and eczema ”. ARB members were advised not to accept such claims in future advertising.
In 1075 – Homemark Aragan Secret Nail Treatment – Dr Harris Steinman (24 November 2020), the Advertiser failed to submit evidence to show that its Aragan Nail Oil is capable of repairing or treating ingrown nails, thick nails, broken nails, flaky nails, brittle nails or deformed nails as claimed and/or implied in its advertising. ARB members were again advised not to accept such claims in future advertising.
In an alert issued to its members on 10 December 2020, the ARB Directorate referred to its 2019 ruling issued against the claims to “fight fungus and eczema” and noted that the Advertiser was still promoting its product with these unsubstantiated claims. All members were advised not to accept such claims from the Advertiser.
From the above, it would appear that the Advertiser had not substantiated any claim to fight fungus and eczema, and has not substantiated any claim that this product is capable of treating ingrown, thick, broken, flaky, brittle or deformed nails. Making claims to this effect would, therefore, clearly be a breach of these earlier rulings.
Both complainants noted that the advertising at issue still claimed to treat fungus and eczema, which the Advertiser denied. The copy of the television commercial provided to the Directorate makes no such claim, which suggests that the Advertiser may be correct in suggesting that the broadcaster flighted the incorrect commercial.
Given that there appears to be no reference to “fungus” or “eczema” in the current commercial, this aspect of the breach complaint is dismissed.
However, this is not the end of the matter. As noted in the ruling issued on 24 November 2020, any claim that the product is capable of treating or repairing ingrown nails, thick nails, broken nails, flaky nails, brittle nails or deformed nails would still be problematic, as evidence of this has not yet been presented to the ARB.
To this end, the Advertiser was afforded an opportunity to respond to the current allegations in terms of Clause 4.1 of Section II of the Code, which requires advertisers to provide independent, objective evidence for any claims capable of substantiation. It provided no evidence, but submitted that the product can claim to be “tried and tested ” by virtue of the fact that it is sold in the European Union, which could not occur unless rigorous testing standards were adhered to. However, no evidence of such rigorous testing, product approval or any efficacy was submitted.
The commercial features, inter alia, a clear animation showing damaged and unhealthy- looking nails being treated with this product, and ultimately being repaired to the point that it appears smooth, clear and healthy. The relevant images are included below:
| Discoloured nail receiving oil. | Discoloured and damaged nail. | Healthy looking nail. |
It also features a shot of the product packaging, which shows a clear “Before” and “After” type image, implying nail repair and healing:
A similar packaging shot also appears at the end of the commercial.
The Directorate accepts that there are no overt references to repairing “ingrown, thick, flaky, brittle” nails. However, the visuals referenced above, along with repeated images of people applying this product to their fingernails or toenails, clearly still communicate the same message. The implied efficacy is reinforced by the voice-over statement that it will “keep your nails smooth and attractive” along with on-screen claims such as “Strong” and “Moisturised”.
Viewed as a whole, the communication to consumers is still that this product, when applied to your nails, will result in a similar “before” and “after” experience, ultimately delivering smooth, clear and healthy-looking nails. The implied efficacy is also evident in the product name “Aragan Secret Nail Treatment” oil (emphasis added).
Despite being afforded an opportunity to submit evidence, and despite alluding to “rigorous EU consumer standards”, the Advertiser has not placed any evidence or other acceptable proof before the Directorate.
In the absence of any evidence to this effect, it would appear that the commercial and implied efficacy claims are in breach of Clause 4.1 of Section II of the Code.
Dealing with the “tried and tested” component of this dispute, the Directorate notes that this may, in certain contexts, be regarded as nothing more than typical advertising jargon aimed at propping up a product or service. However, in the context of implied efficacy claims such as those highlighted above, it implies that the product has, at least by reasonable standards, been tested and found to deliver on consumer expectations. This is particularly true when the claims imply some scientific efficacy. The consumer would understand “tried and tested” to refer to some level of scientific testing.
As noted earlier, no evidence of any testing, let alone evidence of efficacy, has been put before the Directorate.
Accordingly, there appears to be no justification for the claim that this product is “tried and tested”, meaning that the claim is likely to mislead consumers in a way that Clause 4.2.1 of Section II seeks to prevent.
In addition, given that the overall communication is not too dissimilar to that which was ruled against in the 1075 – Homemark Aragan Secret Nail Treatment – Dr Harris Steinman (24 November 2020) matter, it would appear that this commercial is in breach of that decision, rendering the Advertiser in breach of Clause 15 of the Procedural Guide.
Instruction to members
Members are instructed not to accept the advertisement from the Advertiser that:
- make direct or implied claims (including visual claims) that the product is capable of treating or repairing nails or nail
- Claims “tried and tested”.
Leave a Reply